Moderna's personalized cancer vaccine cleared Phase 3 with a learned selector inside it
This story is from 2026-08-23. It is preserved in the archive; the latest stories are on the live feed.
Moderna announced on August 19, 2026 that its individualized cancer treatment intismeran autogene, given with Merck's pembrolizumab, produced positive topline Phase 3 results in patients whose stage two to four melanoma had been completely surgically removed. In Moderna's own words it is the "first…
Read the full story at DEV Community — Machine Learning ↗
Timeline · 1 report
- 2026-08-23 03:09 · DEV Community — Machine Learning
Moderna's personalized cancer vaccine cleared Phase 3 with a learned selector inside it